SG
ANGO icon

StoneX Group’s AngioDynamics ANGO Stock Holding History

StoneX Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$729K Buy
64,109
+11,562
+22% +$125K 0.04% 331
2025
Q4 		$675K Sell
52,547
-1,425
-3% -$17.6K 0.03% 445
2025
Q3 		$603K Sell
53,972
-20,419
-27% -$197K 0.03% 483
2025
Q2 		$738K Sell
74,391
-243
-0.3% -$2.38K 0.04% 408
2025
Q1 		$701K Sell
74,634
-32,449
-30% -$341K 0.04% 372
2024
Q4 		$981K Buy
+107,083
New +$787K 0.05% 286

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

StoneX Group's ANGO Position: Q1 2026 in Review

StoneX Group increased its AngioDynamics (ANGO) stake by 22% in Q1 2026, buying an estimated $125K and bringing the position to 64,109 shares worth $729K. The position accounts for 0.04% of the portfolio, ranked #331.

StoneX Group first reported a position in ANGO in Q4 2024 and has held it in 6 quarters since. The position peaked at $981K in Q4 2024. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • StoneX Group held 64,109 shares of AngioDynamics worth $729K as of Q1 2026.
  • StoneX Group bought 11,562 AngioDynamics shares in Q1 2026, an estimated $125K.
  • AngioDynamics made up 0.04% of StoneX Group's portfolio in Q1 2026, its #331 holding.
  • StoneX Group first reported a position in AngioDynamics in Q4 2024 and has held it in 6 quarters since.
  • StoneX Group's AngioDynamics position peaked at $981K in Q4 2024.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.